Ngi mun tng cng dng cht cho da
Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 Randomized Clinical Trial
El fabricante del medicamento, Novo Nordisk, dijo que los resultados de las pldoras de semaglutida eran incluso mejores si los pacientes tomaban las tabletas segn las indicaciones, reduciendo el peso en poco menos del 17% en comparacin con el 3% del placebo
The performance and interrater agreement of vibration perception for the diagnosis of loss of protective sensation in people with diabetes mellitus
In rare cases, more serious side effects like pancreatitis, gallbladder disease, complications of diabetes-related retina disease (diabetic retinopathy), allergic reactions, and thyroid tumors (in animal studies) have been reported, although the long-term human risk for these outcomes is still being researched